image
Healthcare - Biotechnology - NASDAQ - US
$ 52.8
-18.3 %
$ 2.91 B
Market Cap
-26.4
P/E
BALANCE SHEET
711 M ASSETS
-13.79%
257 M LIABILITIES
-24.49%
455 M EQUITY
-6.30%
BALANCE SHEET DECOMPOSITION
Balance Sheet Arcellx, Inc.
image
Current Assets 599 M
Cash & Short-Term Investments 588 M
Receivables 0
Other Current Assets 11.7 M
Non-Current Assets 112 M
Long-Term Investments 38.3 M
PP&E 70.2 M
Other Non-Current Assets 3.5 M
82.60 %5.38 %9.88 %Total Assets$711.3m
Current Liabilities 125 M
Accounts Payable 2.1 M
Short-Term Debt 7.54 M
Other Current Liabilities 116 M
Non-Current Liabilities 131 M
Long-Term Debt 46.5 M
Other Non-Current Liabilities 84.6 M
2.94 %45.13 %18.14 %32.97 %Total Liabilities$256.5m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018
ASSETS
Cash & Cash Equivalents 105.7 394.6 64.2 104.6 46.6 34.6 14.5
Short Term Investments 481.7 307.4 190.7 73.8 0 0 0
Receivables 0 0 0 0 0 0 0
Inventory 0 0 0 0 0 0 0
Other Current Assets 11.9 14.3 12.0 8.2 2.8 3.5 99 K
Total Current Assets 599.3 716.4 266.9 112.8 49.4 38.1 14.6
PP&E 70.2 69.8 39.9 10.3 4.9 4.3 0.8
Intangible Assets 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0
Long Term Investments 38.3 27.2 2.5 0.2 0.2 0.1 0
Other Long Term Assets 3.5 11.8 4.6 5.5 3.2 1.1 0.4
Other Assets 0 1 0 0 0 0 0
Total Assets 711.3 825.1 313.8 128.8 57.7 43.6 15.8
LIABILITIES
Accounts Payable 2.1 2.6 9.1 1.3 0.5 1.7 1.1
Short Term Debt 7.5 47.8 36.0 0 0 0 0
Other Current Liabilities 56.7 18.3 11.7 13.5 4.8 1.3 0.8
Total Current Liabilities 125.4 118.2 56.7 14.8 5.3 3.0 1.8
Long Term Debt 46.5 50.8 52.2 0 0 0 0
Deferred Tax Income 0 0 0 0 0 0 0
Other Liabilities 8.6 0 0 235.5 116.1 73.3 0
Total Liabilities 256.5 339.8 108.9 250.3 121.4 76.3 1.8
EQUITY
Common Stock 53 K 52 K 44 K 1 K 1 K 1 K 1 K
Retained Earnings (496.8) (389.5) (318.8) (130.1) (65.1) (33.0) (15.1)
Other Accumulative Comprehensive Income/Loss 0.8 0.5 (0.2) 20 K (114.3) (71.5) 0
Total Equity 454.8 485.4 205.0 (121.5) (63.7) (32.7) 14.0
Total Liabilities and Equity 711.3 825.1 313.8 128.8 57.7 43.6 15.8
SHARES OUTSTANDING
Common Shares Outstanding 53.6 48.1 44.1 33.5 21.8 34.8 0.2